{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T20:51:53Z","timestamp":1781211113011,"version":"3.54.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003176","name":"Ministerio de Educaci\u00f3n, Cultura y Deporte","doi-asserted-by":"publisher","award":["FPU13\/04819"],"award-info":[{"award-number":["FPU13\/04819"]}],"id":[{"id":"10.13039\/501100003176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003176","name":"Ministerio de Educaci\u00f3n, Cultura y Deporte","doi-asserted-by":"publisher","award":["FPU14-01610"],"award-info":[{"award-number":["FPU14-01610"]}],"id":[{"id":"10.13039\/501100003176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016658","name":"Plan Nacional sobre Drogas","doi-asserted-by":"publisher","award":["PND2017\/043"],"award-info":[{"award-number":["PND2017\/043"]}],"id":[{"id":"10.13039\/100016658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI16\/01698"],"award-info":[{"award-number":["PI16\/01698"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI16\/01953"],"award-info":[{"award-number":["PI16\/01953"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI17-02026"],"award-info":[{"award-number":["PI17-02026"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["RD16\/0017\/0001"],"award-info":[{"award-number":["RD16\/0017\/0001"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PSI2015-73156-JIN"],"award-info":[{"award-number":["PSI2015-73156-JIN"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["CD14\/00259"],"award-info":[{"award-number":["CD14\/00259"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.neuropharm.2018.01.033","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T14:18:55Z","timestamp":1517408335000},"page":"189-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Systemic blockade of LPA1\/3 lysophosphatidic acid receptors by ki16425 modulates the effects of ethanol on the brain and behavior"],"prefix":"10.1016","volume":"133","author":[{"given":"Laura","family":"S\u00e1nchez-Mar\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ladr\u00f3n de Guevara-Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Carmen","family":"Ma\u00f1as-Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Al\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rom\u00e1n D.","family":"Moreno-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caridad","family":"D\u00edaz-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"P\u00e9rez-del Palacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Garc\u00eda-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Pedraza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Pav\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Rodr\u00edguez de Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis J.","family":"Sant\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4496-1167","authenticated-orcid":false,"given":"Estela","family":"Castilla-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.01.033_bib1","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1017\/S1461145713000217","article-title":"Increased alcohol consumption in rats after subchronic antidepressant treatment","volume":"16","author":"Alen","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib2","doi-asserted-by":"crossref","first-page":"48737","DOI":"10.1074\/jbc.M206812200","article-title":"Serum lysophosphatidic acid is produced through diverse phospholipase pathways","volume":"277","author":"Aoki","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/abio.2001.5063","article-title":"Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry","volume":"292","author":"Baker","year":"2001","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0014-5793(00)01827-5","article-title":"Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors","volume":"478","author":"Bandoh","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.pmbts.2015.10.018","article-title":"Ethanol-associated changes in glutamate reward neurocircuitry: a minireview of clinical and preclinical genetic findings","volume":"137","author":"Bell","year":"2016","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.neuropharm.2018.01.033_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00213-011-2446-6","article-title":"Attenuation of cocaine-induced conditioned locomotion is associated with altered expression of hippocampal glutamate receptors in mice lacking LPA1 receptors","volume":"220","author":"Blanco","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2018.01.033_bib7","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/sj.npp.1301274","article-title":"Role of endocannabinoids in alcohol consumption and intoxication: studies of mice lacking fatty acid amide hydrolase","volume":"32","author":"Blednov","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.01.033_bib8","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.neuropharm.2009.01.007","article-title":"Deletion of vanilloid receptor (TRPV1) in mice alters behavioral effects of ethanol","volume":"56","author":"Blednov","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.01.033_bib9","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/acer.12992","article-title":"Effects of chronic stress on alcohol reward- and anxiety-related behavior in high- and low-alcohol preferring mice","volume":"40","author":"Breit","year":"2016","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib10","doi-asserted-by":"crossref","first-page":"e85348","DOI":"10.1371\/journal.pone.0085348","article-title":"1-Oleoyl lysophosphatidic acid: a new mediator of emotional behavior in rats","volume":"9","author":"Castilla-Ortega","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2018.01.033_bib11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuropharm.2015.12.010","article-title":"Both genetic deletion and pharmacological blockade of lysophosphatidic acid LPA1 receptor results in increased alcohol consumption","volume":"103","author":"Castilla-Ortega","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.01.033_bib12","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bbr.2012.04.018","article-title":"Hippocampal c-Fos activation in normal and LPA(1)-null mice after two object recognition tasks with different memory demands","volume":"232","author":"Castilla-Ortega","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.nlm.2010.04.003","article-title":"Exploratory, anxiety and spatial memory impairments are dissociated in mice lacking the LPA1 receptor","volume":"94","author":"Castilla-Ortega","year":"2010","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neubiorev.2016.03.030","article-title":"A\u00a0place for the hippocampus in the cocaine addiction circuit: potential roles for adult hippocampal neurogenesis","volume":"66","author":"Castilla-Ortega","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1742-2094-11-37","article-title":"Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes","volume":"11","author":"Crack","year":"2014","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2018.01.033_bib16","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/ajad.12463","article-title":"Review: pharmacogenetics of alcoholism treatment: implications of ethnic diversity","volume":"26","author":"Cservenka","year":"2017","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0741-8329(02)00236-7","article-title":"Separate measures of ethanol seeking and drinking in the rat: effects of remoxipride","volume":"28","author":"Czachowski","year":"2002","journal-title":"Alcohol"},{"key":"10.1016\/j.neuropharm.2018.01.033_bib18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.pharmtox.010909.105753","article-title":"LPA receptors: subtypes and biological actions","volume":"50","author":"Choi","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib19","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/cercor\/bhm132","article-title":"Absence of LPA1 signaling results in defective cortical development","volume":"18","author":"Estivill-Torrus","year":"2008","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2018.01.033_bib20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.35946\/arcr.v37.1.09","article-title":"Neuroplasticity in human alcoholism: studies of extended abstinence with potential treatment implications","volume":"37","author":"Fein","year":"2015","journal-title":"Alcohol Res"},{"key":"10.1016\/j.neuropharm.2018.01.033_bib21","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1530-0277.2006.00096.x","article-title":"Increased consumption but not operant self-administration of ethanol in mice lacking the RIIbeta subunit of protein kinase A","volume":"30","author":"Ferraro","year":"2006","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib22","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1007\/s00429-014-0885-7","article-title":"Loss of lysophosphatidic acid receptor LPA1 alters oligodendrocyte differentiation and myelination in the mouse cerebral cortex","volume":"220","author":"Garcia-Diaz","year":"2015","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pnpbp.2014.05.003","article-title":"Alcohol and adult hippocampal neurogenesis: promiscuous drug, wanton effects","volume":"54","author":"Geil","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.01.033_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00441-010-0977-5","article-title":"LPA receptor expression in the central nervous system in health and following injury","volume":"341","author":"Goldshmit","year":"2010","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bbr.2016.01.023","article-title":"Nest building is a novel method for indexing severity of alcohol withdrawal in mice","volume":"302","author":"Greenberg","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.physbeh.2016.08.006","article-title":"Effects of acute alcohol withdrawal on nest building in mice selectively bred for alcohol withdrawal severity","volume":"165","author":"Greenberg","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00213-008-1251-3","article-title":"Reference-dose place conditioning with ethanol in mice: empirical and theoretical analysis","volume":"201","author":"Groblewski","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2018.01.033_bib28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/jnr.10594","article-title":"RhoA and lysophosphatidic acid are involved in the actin cytoskeleton reorganization of astrocytes exposed to ethanol","volume":"72","author":"Guasch","year":"2003","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib29","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.mcn.2003.09.001","article-title":"LPA1 receptor-deficient mice have phenotypic changes observed in psychiatric disease","volume":"24","author":"Harrison","year":"2003","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.yexcr.2014.11.020","article-title":"Lysophospholipid receptors in drug discovery","volume":"333","author":"Kihara","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jad.2017.03.026","article-title":"Gintonin attenuates depressive-like behaviors associated with alcohol withdrawal in mice","volume":"215","author":"Kim","year":"2017","journal-title":"J.\u00a0Affect. Disord."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib32","doi-asserted-by":"crossref","first-page":"796","DOI":"10.14348\/molcells.2015.0116","article-title":"Oral administration of gintonin attenuates cholinergic impairments by scopolamine, amyloid-beta protein, and mouse model of Alzheimer's disease","volume":"38","author":"Kim","year":"2015","journal-title":"Mol. Cell."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib33","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/alcalc\/34.5.685","article-title":"Operant responding for ethanol in rats with a long-term history of free-choice ethanol drinking","volume":"34","author":"Koros","year":"1999","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.neuropharm.2018.01.033_bib34","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/ATVBAHA.114.304748","article-title":"Possible involvement of minor lysophospholipids in the increase in plasma lysophosphatidic acid in acute coronary syndrome","volume":"35","author":"Kurano","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib35","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1101\/lm.042192.116","article-title":"Effects of drugs of abuse on hippocampal plasticity and hippocampus-dependent learning and memory: contributions to development and maintenance of addiction","volume":"23","author":"Kutlu","year":"2016","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib36","first-page":"323","article-title":"Long-lasting memory deficits in mice withdrawn from cocaine are concomitant with neuroadaptations in hippocampal basal activity, GABAergic interneurons and adult neurogenesis","volume":"10","author":"Ladron de Guevara-Miranda","year":"2017","journal-title":"Dis. Mol. Med."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib37","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00213-013-3177-7","article-title":"Modulation of ethanol-induced conditioned place preference in mice by 3-amino-1,2,4-triazole and D-penicillamine depends on ethanol dose and number of conditioning trials","volume":"230","author":"Ledesma","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2018.01.033_bib38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12944-015-0071-9","article-title":"Plasma levels of lysophosphatidic acid in ovarian cancer versus controls: a meta-analysis","volume":"14","author":"Li","year":"2015","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib39","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.prostaglandins.2009.02.002","article-title":"Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance","volume":"91","author":"Lin","year":"2010","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib40","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.alcohol.2014.02.002","article-title":"Operant ethanol self-administration in ethanol dependent mice","volume":"48","author":"Lopez","year":"2014","journal-title":"Alcohol"},{"key":"10.1016\/j.neuropharm.2018.01.033_bib41","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1530-0277.2011.01717.x","article-title":"Repeated cycles of chronic intermittent ethanol exposure leads to the development of tolerance to aversive effects of ethanol in C57BL\/6J mice","volume":"36","author":"Lopez","year":"2012","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.plipres.2015.01.004","article-title":"Lysophosphatidic acid receptor (LPAR) modulators: the current pharmacological toolbox","volume":"58","author":"Llona-Minguez","year":"2015","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib43","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.mcn.2008.07.014","article-title":"Deletion of lysophosphatidic acid receptor LPA1 reduces neurogenesis in the mouse dentate gyrus","volume":"39","author":"Matas-Rico","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib44","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1111\/j.1530-0277.2010.01240.x","article-title":"Withdrawal severity after chronic intermittent ethanol in inbred mouse strains","volume":"34","author":"Metten","year":"2010","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib45","doi-asserted-by":"crossref","first-page":"e1077","DOI":"10.1038\/tp.2017.24","article-title":"maLPA1-null mice as an endophenotype of anxious depression","volume":"7","author":"Moreno-Fern\u00e1ndez","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.01.033_bib46","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1017\/S1461145710001240","article-title":"Abnormalities in alpha\/beta-CaMKII and related mechanisms suggest synaptic dysfunction in hippocampus of LPA1 receptor knockout mice","volume":"14","author":"Musazzi","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib47","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1124\/mol.64.4.994","article-title":"Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors","volume":"64","author":"Ohta","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00213-002-1248-2","article-title":"A\u00a0role for corticotropin releasing factor (CRF) in ethanol consumption, sensitivity, and reward as revealed by CRF-deficient mice","volume":"165","author":"Olive","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2018.01.033_bib49","first-page":"820","article-title":"Effects of 4-methylpyrazole on ethanol neurobehavioral toxicity in CD-1 mice","volume":"11","author":"Paez","year":"2004","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib50","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00429-013-0592-9","article-title":"Fear extinction and acute stress reactivity reveal a role of LPA(1) receptor in regulating emotional-like behaviors","volume":"219","author":"Pedraza","year":"2014","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib51","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1038\/npp.2015.80","article-title":"Nicotinic mechanisms modulate ethanol withdrawal and modify time course and symptoms severity of simultaneous withdrawal from alcohol and nicotine","volume":"40","author":"Perez","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.01.033_bib52","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.alcohol.2015.02.003","article-title":"Assessment of affective and somatic signs of ethanol withdrawal in C57BL\/6J mice using a short-term ethanol treatment","volume":"49","author":"Perez","year":"2015","journal-title":"Alcohol"},{"key":"10.1016\/j.neuropharm.2018.01.033_bib53","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pbb.2015.02.021","article-title":"Ethanol impairment of spontaneous alternation behaviour and associated changes in medial prefrontal glutamatergic gene expression precede putative markers of dependence","volume":"132","author":"Pickering","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3390\/ijms17020215","article-title":"G-Protein-coupled lysophosphatidic acid receptors and their regulation of AKT signaling","volume":"17","author":"Riaz","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib55","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.mp.4000206","article-title":"Differential sensitivity of c-Fos expression in hippocampus and other brain regions to moderate and low doses of alcohol","volume":"2","author":"Ryabinin","year":"1997","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib56","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1601-183X.2009.00524.x","article-title":"Behavioral phenotype of maLPA1-null mice: increased anxiety-like behavior and spatial memory deficits","volume":"8","author":"Santin","year":"2009","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib57","doi-asserted-by":"crossref","first-page":"10224","DOI":"10.1523\/JNEUROSCI.4703-14.2015","article-title":"Activation of lysophosphatidic acid receptor type 1 contributes to pathophysiology of spinal cord injury","volume":"35","author":"Santos-Nogueira","year":"2015","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib58","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1097\/01.ALC.0000139825.35438.A4","article-title":"Chronic ethanol-induced subtype- and subregion-specific decrease in the mRNA expression of metabotropic glutamate receptors in rat hippocampus","volume":"28","author":"Simonyi","year":"2004","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib59","first-page":"1","article-title":"Promising pharmacological directions in the world of lysophosphatidic Acid signaling","volume":"23","author":"Stoddard","year":"2015","journal-title":"Biol. Ther."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib60","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.neuroimage.2012.01.117","article-title":"Resting state functional connectivity in addiction: Lessons learned and a road ahead","volume":"62","author":"Sutherland","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2018.01.033_bib61","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/HRP.0000000000000079","article-title":"Pharmacotherapy for alcohol use disorder: current and emerging therapies","volume":"23","author":"Swift","year":"2015","journal-title":"Harv. Rev. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib62","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bbr.2006.05.010","article-title":"Locomotor effects of ethanol and acetaldehyde after peripheral and intraventricular injections in Swiss and C57BL\/6J mice","volume":"172","author":"Tambour","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib63","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1476-5381.2010.00815.x","article-title":"Aiming drug discovery at lysophosphatidic acid targets","volume":"161","author":"Tigyi","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib64","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1046\/j.1471-4159.2003.01993.x","article-title":"Protective effects of lysophosphatidic acid (LPA) on chronic ethanol-induced injuries to the cytoskeleton and on glucose uptake in rat astrocytes","volume":"87","author":"Tomas","year":"2003","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib65","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1369-1600.2007.00070.x","article-title":"Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade","volume":"12","author":"Tzschentke","year":"2007","journal-title":"Addict Biol"},{"key":"10.1016\/j.neuropharm.2018.01.033_bib66","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.stemcr.2016.03.002","article-title":"Lysophosphatidic acid receptor is a functional marker of adult hippocampal precursor cells","volume":"6","author":"Walker","year":"2016","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.neuropharm.2018.01.033_bib67","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/01.mcg.0000225642.90898.0e","article-title":"Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C","volume":"41","author":"Watanabe","year":"2007","journal-title":"J.\u00a0Clin. Gastroenterol."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib68","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00008877-199702000-00004","article-title":"Strain differences in ethanol preference and reinforced behaviour: a comparison of two-bottle choice and operant self-administration paradigms","volume":"8","author":"Wilson","year":"1997","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib69","series-title":"Global Status Report on Alcohol and Health","author":"World Health Organization, W","year":"2014"},{"key":"10.1016\/j.neuropharm.2018.01.033_bib70","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00702-014-1289-9","article-title":"Lysophosphatidic acid induces anxiety-like behavior via its receptors in mice","volume":"122","author":"Yamada","year":"2015","journal-title":"J.\u00a0Neural. Transm."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib71","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.alcohol.2007.12.006","article-title":"Voluntary ethanol consumption in 22 inbred mouse strains","volume":"42","author":"Yoneyama","year":"2008","journal-title":"Alcohol"},{"key":"10.1016\/j.neuropharm.2018.01.033_bib72","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1194\/jlr.R046458","article-title":"LPA receptor signaling: pharmacology, physiology, and pathophysiology","volume":"55","author":"Yung","year":"2014","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib73","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput. Meth. Progr. Biomed."},{"key":"10.1016\/j.neuropharm.2018.01.033_bib74","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1530-0277.2010.01338.x","article-title":"Ethanol-induced alterations in fatty acid-related lipids in serum and tissues in mice","volume":"35","author":"Zhao","year":"2011","journal-title":"Alcohol Clin. Exp. Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818300339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818300339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:35:41Z","timestamp":1777426541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818300339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":74,"alternative-id":["S0028390818300339"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.01.033","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic blockade of LPA1\/3 lysophosphatidic acid receptors by ki16425 modulates the effects of ethanol on the brain and behavior","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.01.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}